HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
K Akassoglou Selected Research
K Akassoglou Research Topics
Disease
4
Inflammation (Inflammations)
03/2019 - 10/2000
2
Multiple Sclerosis
01/2007 - 10/2000
2
Demyelinating Diseases (Demyelinating Disease)
10/2000 - 05/2000
1
Neuroinflammatory Diseases
03/2019
1
Neurocognitive Disorders (Clerambault Syndrome)
03/2019
1
Neurodegenerative Diseases (Neurodegenerative Disease)
07/2009
1
Rheumatoid Arthritis
01/2007
1
Bacterial Infections (Bacterial Infection)
01/2007
1
Myocardial Infarction
01/2007
1
Rupture
01/2007
1
Sepsis (Septicemia)
01/2007
1
Atherosclerosis
10/2001
1
Central Nervous System Diseases (CNS Diseases)
10/2000
1
Necrosis
10/2000
Drug/Important Bio-Agent (IBA)
2
Blood Proteins (Serum Proteins)
IBA
07/2009 - 01/2007
2
Fibrinogen (Factor I)
FDA Link
07/2009 - 01/2007
2
Ligands
IBA
01/2007 - 10/2000
1
7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acid
IBA
03/2019
1
Lipids
IBA
03/2019
1
Nexus
IBA
01/2007
1
Blood Coagulation Factors (Coagulation Factor)
IBA
01/2007
1
Integrins
IBA
01/2007
1
Biomarkers (Surrogate Marker)
IBA
10/2001
1
Plasminogen Activators (Plasminogen Activator)
IBA
10/2001
1
Lymphotoxin-alpha (Lymphotoxin)
IBA
10/2000
1
Type I Tumor Necrosis Factor Receptors
IBA
10/2000
1
Type II Tumor Necrosis Factor Receptors
IBA
10/2000
1
Plasminogen
IBA
05/2000
1
Tissue Plasminogen Activator (Alteplase)
FDA Link
05/2000
Therapy/Procedure
1
Investigational Therapies (Experimental Therapy)
10/2000